BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 28802027)

  • 1. Performance Evaluation of the Bioneer AccuPower® HIV-1 Quantitative RT-PCR kit: Comparison with the Roche COBAS® AmpliPrep/COBAS TaqMan® HIV-1 Test Ver.2.0 for Quantification of HIV-1 Viral Load in Indonesia.
    Kosasih AS; Sugiarto C; Hayuanta HH; Juhaendi R; Setiawan L
    Asian Pac J Allergy Immunol; 2018 Jun; 36(2):120-125. PubMed ID: 28802027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High correlation between the Roche COBAS® AmpliPrep/COBAS® TaqMan® HIV-1, v2.0 and the Abbott m2000 RealTime HIV-1 assays for quantification of viral load in HIV-1 B and non-B subtypes.
    Karasi JC; Dziezuk F; Quennery L; Förster S; Reischl U; Colucci G; Schoener D; Seguin-Devaux C; Schmit JC
    J Clin Virol; 2011 Nov; 52(3):181-6. PubMed ID: 21813320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between the automated Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 assay and its version 1 and Nuclisens HIV-1 EasyQ version 2.0 assays when measuring diverse HIV-1 genotypes in China.
    Xu S; Song A; Nie J; Li X; Meng S; Zhang C; Wang Y
    J Clin Virol; 2012 Jan; 53(1):33-7. PubMed ID: 22051503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance evaluation of the new Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 for quantification of human immunodeficiency virus type 1 RNA.
    Pas S; Rossen JW; Schoener D; Thamke D; Pettersson A; Babiel R; Schutten M
    J Clin Microbiol; 2010 Apr; 48(4):1195-200. PubMed ID: 20164281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 test v1.0 with v2.0 in HIV-1 viral load quantification.
    Tung YC; Ke LY; Lu PL; Lin KH; Lee SC; Lin YY; Chou LC; Tsai WC
    Kaohsiung J Med Sci; 2015 Apr; 31(4):188-93. PubMed ID: 25835274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 (CAP/CTM v2.0) with other real-time PCR assays in HIV-1 monitoring and follow-up of low-level viral loads.
    Wojewoda CM; Spahlinger T; Harmon ML; Schnellinger B; Li Q; Dejelo C; Schmotzer C; Zhou L
    J Virol Methods; 2013 Jan; 187(1):1-5. PubMed ID: 23098667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter evaluation of the cobas® HIV-1 quantitative nucleic acid test for use on the cobas® 4800 system for the quantification of HIV-1 plasma viral load.
    Adams P; Vancutsem E; Nicolaizeau C; Servais JY; Piérard D; François JH; Schneider T; Paxinos EE; Marins EG; Canchola JA; Seguin-Devaux C
    J Clin Virol; 2019 May; 114():43-49. PubMed ID: 30991164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative RNA quantification of HIV-1 group M and non-M with the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 v2.0 and Abbott Real-Time HIV-1 PCR assays.
    Sire JM; Vray M; Merzouk M; Plantier JC; Pavie J; Maylin S; Timsit J; Lascoux-Combe C; Molina JM; Simon F; Delaugerre C
    J Acquir Immune Defic Syndr; 2011 Mar; 56(3):239-43. PubMed ID: 21164353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction of underquantification of human immunodeficiency virus type 1 load with the second version of the Roche Cobas AmpliPrep/Cobas TaqMan assay.
    De Bel A; Marissens D; Debaisieux L; Liesnard C; Van den Wijngaert S; Lauwers S; Piérard D
    J Clin Microbiol; 2010 Apr; 48(4):1337-42. PubMed ID: 20164284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishing diagnostic cut-off criteria for the COBAS AmpliPrep/COBAS TaqMan HIV-1 Qualitative test through validation against the Amplicor DNA test v1.5 for infant diagnosis using dried blood spots.
    Maritz J; Preiser W; van Zyl GU
    J Clin Virol; 2012 Feb; 53(2):106-9. PubMed ID: 22196872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the performance of Abbott m2000 and Roche COBAS Ampliprep/COBAS Taqman assays for HIV-1 viral load determination using dried blood spots and dried plasma spots in Kenya.
    Zeh C; Ndiege K; Inzaule S; Achieng R; Williamson J; Chih-Wei Chang J; Ellenberger D; Nkengasong J
    PLoS One; 2017; 12(6):e0179316. PubMed ID: 28622370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the cobas Human Immunodeficiency Virus 1 (HIV-1) Test Using the cobas 4800 System With COBAS AmpliPrep/COBAS TaqMan HIV-1 Test and Abbott RealTime HIV-1 Assay and Performance Evaluation of cobas HIV-1.
    Shin KH; Lee HJ; Lee JH; Chang CL; Kim HH
    Am J Clin Pathol; 2019 Oct; 152(5):558-562. PubMed ID: 31365738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of dilution of plasma samples with phosphate buffered saline to eliminate the problem of small volumes associated with children infected with HIV-1 for viral load testing using Cobas AmpliPrep/COBAS TaqMan HIV-1 test, version 2.0 (CAP CTM HIV v2.0).
    Mine M; Nkoane T; Sebetso G; Sakyi B; Makhaola K; Gaolathe T
    J Virol Methods; 2013 Dec; 194(1-2):217-21. PubMed ID: 24025342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial evaluation of the Roche COBAS TaqMan HIV-1 v2.0 assay for determining viral load in HIV-infected individuals.
    Taylor N; Schmid I; Egle A; Greil R; Patsch W; Oberkofler H
    Antivir Ther; 2009; 14(8):1189-93. PubMed ID: 20032549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of a new in-house HIV-1 TaqMan real-time PCR and three commercial HIV-1 RNA quantitative assays.
    Noorbazargan H; Nadji SA; Mirab Samiee S; Paryan M; Mohammadi-Yeganeh S
    Comp Immunol Microbiol Infect Dis; 2018 Aug; 59():1-7. PubMed ID: 30290882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the NucliSens EasyQ v2.0 assay in comparison with the Roche Amplicor v1.5 and the Roche CAP/CTM HIV-1 Test v2.0 in quantification of C-clade HIV-1 in plasma.
    Muenchhoff M; Madurai S; Hempenstall AJ; Adland E; Carlqvist A; Moonsamy A; Jaggernath M; Mlotshwa B; Siboto E; Ndung'u T; Goulder PJ
    PLoS One; 2014; 9(8):e103983. PubMed ID: 25157919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the Hologic Aptima HIV-1 Quant Dx Assay to the Roche COBAS Ampliprep/COBAS TaqMan HIV-1 Test v2.0 for the quantification of HIV-1 RNA in plasma samples.
    Schønning K; Johansen K; Landt B; Benfield T; Westh H
    J Clin Virol; 2017 Jul; 92():14-19. PubMed ID: 28505569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the QIAGEN artus HBV QS-RGQ Assay With the Roche COBAS AmpliPrep/COBAS TaqMan HBV Assay for Quantifying Viral DNA in Sera of Chronic Hepatitis B Patients.
    Han MS; Park Y; Nah H; Kim HS
    Ann Lab Med; 2017 May; 37(3):248-253. PubMed ID: 28224771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of the COBAS AmpliPrep/COBAS TaqMan HIV type 1 test (CAP/CTM) and VERSANT HIV type 1 RNA 3.0 assay (bDNA) for quantifying HIV type 1 viral loads in China.
    Xu S; Song A; Nie J; Li X; Li J; Bao Z; Wang Y
    AIDS Res Hum Retroviruses; 2008 Nov; 24(11):1365-73. PubMed ID: 18928395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the QIAGEN artus HIV-1 QS-RGQ test with the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 test v2.0.
    Wall GR; Perinpanathan D; Clark DA
    J Clin Virol; 2012 Sep; 55(1):62-6. PubMed ID: 22739101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.